Discovery of Antivirulence Agents against Methicillin-Resistant Staphylococcus aureus

Two small-molecule compounds discovered inhibit the production of the toxins alpha-hemolysin and phenol-soluble modulin α in a dose-dependent manner without inhibiting bacterial growth and are the FDA-approved nonsteroidal anti-inflammatory drug diflunisal, a new use for an old drug.